Mesa Laboratories Inc Market Cap ($578.17 Million)
Market Cap & Net Worth: Mesa Laboratories Inc (MLAB)
Mesa Laboratories Inc market cap. Mesa Laboratories Inc (NASDAQ:MLAB) has a market capitalization of $578.17 Million ($578.17 Million) as of October 31, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #11125 globally and #2921 in its home market, demonstrating a -1.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Mesa Laboratories Inc's stock price $127.81 by its total outstanding shares 5524813 (5.52 Million).
Mesa Laboratories Inc Market Cap History (2015–2026)
Mesa Laboratories Inc market cap history from 2015 to 2026. Data shows growth from $530.35 Million to $706.13 Million (1.80% CAGR). Check Mesa Laboratories Inc (MLAB) share price today for real-time trading data and today's change.
Index Memberships
Mesa Laboratories Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$40.09 Trillion | 0.00% | #1146 of 3165 |
|
S&P Small-Cap 600 Index
SML
|
$1.56 Trillion | 0.05% | #535 of 602 |
Weight: Mesa Laboratories Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Mesa Laboratories Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Mesa Laboratories Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Mesa Laboratories Inc cash conversion from operations for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
1.80x
Mesa Laboratories Inc's market cap is 1.80 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $658.25 Million | $84.66 Million | $11.17 Million | 7.78x | 58.94x |
| 2017 | $669.70 Million | $93.67 Million | $11.18 Million | 7.15x | 59.89x |
| 2018 | $1.13 Billion | $96.18 Million | -$2.96 Million | 11.72x | N/A |
| 2019 | $1.35 Billion | $103.14 Million | $7.48 Million | 13.11x | 180.71x |
| 2020 | $1.56 Billion | $117.69 Million | $1.78 Million | 13.24x | 876.40x |
| 2021 | $1.79 Billion | $133.94 Million | $3.27 Million | 13.35x | 546.03x |
| 2022 | $908.60 Million | $184.34 Million | $1.87 Million | 4.93x | 485.62x |
| 2023 | $575.67 Million | $219.08 Million | $930.00K | 2.63x | 619.00x |
| 2024 | $728.56 Million | $216.19 Million | -$254.25 Million | 3.37x | N/A |
| 2025 | $433.70 Million | $240.98 Million | -$1.97 Million | 1.80x | N/A |
Competitor Companies of MLAB by Market Capitalization
Companies near Mesa Laboratories Inc in the global market cap rankings as of October 31, 2026. See Mesa Laboratories Inc balance sheet independence to understand what proportion of total assets are financed by equity.
Key companies related to Mesa Laboratories Inc by market ranking:
- Garmin Ltd (NYSE:GRMN): Ranked #513 globally with a market cap of $52.59 Billion USD.
- Coherent Inc (NYSE:COHR): Ranked #648 globally with a market cap of $41.15 Billion USD.
- Garmin Ltd (F:GEY): Ranked #683 globally with a market cap of $39.27 Billion USD ( €33.59 Billion EUR).
- Keysight Technologies Inc (NYSE:KEYS): Ranked #745 globally with a market cap of $35.96 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #513 | Garmin Ltd | NYSE:GRMN | $52.59 Billion | $272.67 |
| #648 | Coherent Inc | NYSE:COHR | $41.15 Billion | $210.32 |
| #683 | Garmin Ltd | F:GEY | $39.27 Billion | €240.70 |
| #745 | Keysight Technologies Inc | NYSE:KEYS | $35.96 Billion | $307.20 |
Market Capitalization of Mesa Laboratories Inc (2015–2026)
Market capitalization of Mesa Laboratories Inc from 2015 to today. Between 2015 and today, Mesa Laboratories Inc's market cap moved from $530.35 Million to $ 706.13 Million, with a yearly change of 1.80%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $706.13 Million | +62.82% |
| 2025 | $433.70 Million | -40.47% |
| 2024 | $728.56 Million | +26.56% |
| 2023 | $575.67 Million | -36.64% |
| 2022 | $908.60 Million | -49.18% |
| 2021 | $1.79 Billion | +14.73% |
| 2020 | $1.56 Billion | +15.22% |
| 2019 | $1.35 Billion | +20.01% |
| 2018 | $1.13 Billion | +68.27% |
| 2017 | $669.70 Million | +1.74% |
| 2016 | $658.25 Million | +24.12% |
| 2015 | $530.35 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Mesa Laboratories Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $578.17 Million USD |
| MoneyControl | $578.17 Million USD |
| MarketWatch | $578.17 Million USD |
| marketcap.company | $578.17 Million USD |
| Reuters | $578.17 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Mesa Laboratories Inc
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and clean… Read more